Cardinal Health, Inc. CAH
220.22
(2.40)
(1.08%)
as of 25 Sep
- Market cap
- $51.6B
- P/E
- 30.3×
Follow CAH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Cardinal Health, Inc. (CAH) Total debt
Cardinal Health, Inc.'s total debt at the end of fiscal 2026 was $8.9B, unchanged from fiscal 2025. Over the past ten years it has ranged from $4.7B (fiscal 2023) to $10.4B (fiscal 2017); the current reading is higher than 83% of that period. Cardinal Health, Inc. ranks 3rd of 11 Medical Distribution companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $8.9B | 4.21% |
| FY2025 | $8.5B | 67.46% |
| FY2024 | $5.1B | 8.32% |
| FY2023 | $4.7B | (11.55%) |
| FY2022 | $5.3B | (14.77%) |
| FY2021 | $6.2B | (7.96%) |
| FY2020 | $6.8B | (15.64%) |
| FY2019 | $8.0B | (10.90%) |
| FY2018 | $9.0B | (13.29%) |
| FY2017 | $10.4B | 87.67% |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $8.9B | (0.34%) |
| Mar 2026 | $8.9B | (1.23%) |
| Dec 2025 | $9.0B | (0.06%) |
| Sep 2025 | $9.0B | 5.92% |
| 42 more quarters | Free account |
Against its own ten years
Low $4.7B
High $10.4B
Ten-year median
$6.5B
Current reading's percentile
83
Total debt against peers
| Company | Total debt |
|---|---|
| MCK McKesson Corporation compare | $14.8B |
| COR Cencora, Inc. compare | $11.7B |
| CAH Cardinal Health, Inc. | $8.9B |
| HSIC Henry Schein, Inc. compare | $2.4B |
| ACH Accendra Health, Inc. compare | $1.7B |
| FOCL FocalTherics compare | $40.1M |
| YI 111, Inc. Sponsored ADR compare | $37.3M |
| COSM Cosmos Health Inc. compare | $11.8M |
| AHG Akso Health Group Sponsored ADR compare | $4.6M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on CAH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement